武汉大学第二临床学院研究生导师介绍
赵秋
专业技术职称
主任医师 教授
院内行政职务
大内科主任
国外访学经历
1996/09-1996/12, 法国阿鲁特赞克学院胃肠和肝脏病科进修治疗内镜和ERCP;指导老师:J. F. Rey, France 原欧洲内镜学会主席。
所在二级学科名称
内科
所在三级
学科名称
消化内科
导师主要研究方向
胰腺疾病 肝脏疾病
主要学术兼职
(职务及聘任时间)
武汉医学会消化专业委员会 主委 2020年11月
武汉市消化内镜学会 副主委 2018年12月
湖北省消化内镜学会 副主委 2018年
主要社会兼职
(职务及聘任时间)
聘任单位 社会职务名称 聘任时间
中国医师协会消化内镜专业委员会 副主任委员 2016年11月
中华消化内镜学会ERCP学组 委员 2019年6月
医学参考报消化内镜学频道第二届编委会 副主编 2019年
世界华人内镜医师协会 常务委员 2019年
中国卫生信息与健康医疗大数据学会第一届消化专科专业委员会 2019年
世界内镜医师协会消化内镜协会 副会长 2019年
联系方式
办公室电话
67812522
Email
715155196@qq.com
近五年科研情况
近五年发表SCI及统计源以上期刊论文共 55 篇(本人为第一作者或通讯作者)
(其中SCI收录 54篇,单篇论文最高SCI影响因子 17.37 分,累计影响因子 213.763 分)
目前承担的项目共 6 项(国家级 4 项)
有代表性的论文、专著和获奖项等
序
号
成果(论文、专著、获奖项目)名称
成果鉴定、颁奖部门及奖励类别、等级或发表刊物与出版单位、时间
备注如:是否SCI(影响因子)
1
胆胰疾病-现状与进展
2019年5月
2
Pancreatic Injury Patterns in Patients With Coronavirus Disease 19 Pneumonia
2020 07
17.37
3
Author response to Letter to the Editor 'Liver impairment associated with disease progression in COVID-19 patients'
2020 07
5.175
4
Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital
2020 08
7.117
5
Suggestions for infection prevention and control in digestive endoscopy during current 2019-nCoV pneumonia outbreak in Wuhan, Hubei province, China.
2020 04
7.341
6
Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.
2020 04
5.175
7
Lnc-ITSN1-2, Derived From RNA Sequencing, Correlates With Increased Disease Risk, Activity and Promotes CD4+ T Cell Activation, Proliferation and Th1/Th17 Cell Differentiation by Serving as a ceRNA for IL-23R via Sponging miR-125a in Inflammatory Bowel Disease
2020 05
5.085
8
Endoscopic Ultrasound-Fine-Needle Biopsy Is Superior to Endoscopic Ultrasound-Fine-Needle Aspiration in Sampling Pancreatic Masses
2018 03
7.683
9
Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis
2018 01
4.057
10
Carbohydrate and protein intake and risk of ulcerative colitis: Systematic review and dose-response meta-analysis of epidemiological studies
2017 10
5.496
11
JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4(+) T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease
2017 07
5.511
武汉大学第二临床学院研究生导师网页介绍
刘静
专业技术职称
副主任医师/副教授/
博士生导师
院内行政职务
暂无
国外访学经历
NIH纳米医学研究中心,美国辛辛那提大学
所在二级学科名称
内科学
所在三级
学科名称
消化内科
导师主要研究方向
1、肿瘤干细胞与肿瘤微环境
2、非酒精性脂肪肝
主要学术兼职
(职务及聘任时间)
1、湖北省消化学会青年副主委
2、中华医学会消化内镜学分会超声内镜学组青年委员
3、湖北省免疫学会第十届理事会理事
主要社会兼职
(职务及聘任时间)
暂无
联系方式
办公室电话
027-67812665
Email
liujing_GI@whu.edu.cn
近五年科研情况
近五年发表SCI及统计源以上期刊论文共29篇(本人为第一作者或通讯作者)
(其中SCI一区2篇,二区7篇,单篇最高影响因子24.45,总影响因子119.3)
目前承担的项目共 17项(国家自然科学基金面上项目2项,国家重点基础研究发展计划(973项目)1项,省级1项,市级 2项,校级11项)
最有代表性的论文、专著和获奖项目等
序
号
成果(论文、专著、获奖项目)
名 称
成果鉴定、颁奖部门及奖励类别、等级或发表刊物与出版单位、时间
备注
如:是否SCI
(影响因子)
1
Asymptomatic cases in a family cluster with SARS-CoV-2 infection.
The Lancet. Infectious diseases, 2020
通讯作者;IF=24.446
2
Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma.
Journal for immune-
therapy of cancer, 2020
共同通讯作者;IF=9.913
3
Advances into Understanding the Vital Role of the Mitochondrial Citrate Carrier (CIC) in Metabolic Diseases, A Review.
Pharmacological Research, 2020
共同通讯作者;IF=5.893
4
FATP2-targeted therapies - a role beyond fatty liver disease
Pharmacological Research, 2020
通讯作者;IF=5.893
5
Crosstalk between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
Frontiers Immunology, 2020
共同通讯作者;IF=5.085
6
Updated Approaches against SARS-CoV-2
Antimicrobial Agents and Chemotherapy, 2020
通讯作者;IF=4.904
7
The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis
Journal of infection, 2020
通讯作者;IF=4.842
8
Carboxypeptidase A6 was identified and validated as a novel potential biomarker for predicting the occurrence of active ulcerative colitis
Journal of Cellular and Molecular Medicine, 2020
共同通讯作者;IF=4.486
9
SET nuclear proto-oncogene gene expression is associated with microsatellite instability in human colorectal cancer identified by co-expression analysis. Digestive and Liver Disease
Digestive and Liver Disease, 2020
共同通讯作者;IF=3.57
10
Identification of PIGU as the Hub Gene Associated with KRAS Mutation in Colorectal Cancer by Coexpression Analysis.
DNA and Cell Biology, 2020
共同通讯作者;IF=3.191
11
The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis.
Clinics and Research in Hepatology and Gastroenterology, 2020
共同通讯作者;IF=2.718
12
The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: A systematic review and meta-analysis.
International Journal of Colorectal Disease, 2020
通讯作者;IF=2.108
13
Soft fibrin matrix downregulates DAB2IP to promote Nanog-dependent growth of colon tumor-repopulating cells
Cell Death & Disease, 2019
共同通讯作者;IF=6.304
14
Co-expression network analysis identified Plakophilin 1 is associated with the metastasis in human melanoma
Biomedicine & Pharm- acotherapy, 2019
通讯作者;IF=4.545
15
Implication of MyD88 inhibitor TJ-M2010-5 for therapeutic intervention of hepatocellular carcinoma
Hepatology Research, 2019
第一作者;IF=3.165
16
Inhibition of heat shock protein 90 as a novel platform for the treatment of cancer
Current pharmaceutical design, 2019
通讯作者;IF=2.208
17
Pemafibrate tends to have a better efficacy in treating dyslipidemia than fenofibrate
Current Pharmaceutical Design, 2019
共同通讯作者;IF=2.208
18
A novel gene-pair signature for relapse-free survival prediction in colon cancer
Cancer Management and Research, 2018
共同通讯作者;IF=2.886
19
Soft fibrin gels promote selection and growth of tumorigenic cells.
Nature Materials, 2012
第一作者;IF=38.663
20
Fabrication of Stable and RNase-Resistant RNA Nanoparticles Active in Gearing the Nanomotors for Viral DNA Packaging
ACS Nano, 2011
第一作者;IF=14.588
21
Low Dosages: new chemotherapeutic weapons on the battlefield of immune-related diseases.
Cellular & Molecular Immunology, 2011
第一作者;IF=8.484
22
Mast cell: insight into remodeling a tumor microenvironment.
Cancer and metastasis reviews, 2011
第一作者;IF=6.4
23
“四证合一”临床医学专硕科研创新能力培养的探索
中国继续医学教育, 2020
第一作者
24
氩离子凝固术加黏膜下药物注射治疗放射性肠炎初步临床分析
中华放射肿瘤学, 2020
通讯作者
25
“四证合一”医学专业学位研究生培养模式的探索
中国继续教育医学, 2018
通讯作者
26
干细胞移植治疗放射性肠炎的研究进展
临床误诊误治, 2018
通讯作者
删除或更新信息,请邮件至freekaoyan#163.com(#换成@)